FNs, the α5β1 integrin ligand on ECs, are also involved in promoting angiogenesis in a VEGF-independent manner and blocking α5β1 integrin with antibodies, peptides, or antagonists promoting tumor regression (109). Here, VEGFA is linked to neoplasm.